Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs (Q37026080)

17 August 2017

1 reference

title

Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs (English)

1 reference

17 August 2017

cardiovascular disease

1 reference

1 reference

3

Emmanuela Gakidou

1 reference

17 August 2017

Rafael Lozano

6

0 references

Farshad Farzadfar

object named as

Farshad Farzadfar

5

0 references

Anthony Rodgers

object named as

Anthony Rodgers

7

0 references

Thomas A. Gaziano

2

object named as

Thomas A Gaziano

1 reference

17 August 2017

Stephen S Lim

1

1 reference

PubMed ID

18063025

17 August 2017

K Srinath Reddy

4

1 reference

PubMed ID

18063025

17 August 2017

language of work or name

English

0 references

publication date

11 December 2007

1 reference

17 August 2017

1 reference

17 August 2017

370

1 reference

17 August 2017

2054-2062

1 reference

17 August 2017

9604

1 reference

Preventing chronic diseases: how many lives can we save?

17 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961699-7

7 January 2021

Projections of global mortality and burden of disease from 2002 to 2030

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961699-7

7 January 2021

Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961699-7

7 January 2021

Rethinking the "diseases of affluence" paradigm: global patterns of nutritional risks in relation to economic development

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961699-7

7 January 2021

Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961699-7

7 January 2021

WHO Framework Convention on Tobacco Control: development of an evidence based global public health treaty

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961699-7

7 January 2021

Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961699-7

7 January 2021

Scaling up interventions for chronic disease prevention: the evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961699-7

7 January 2021

Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961699-7

7 January 2021

Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961699-7

7 January 2021

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961699-7

7 January 2021

Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961699-7

7 January 2021

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961699-7

7 January 2021

Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961699-7

7 January 2021

A strategy to reduce cardiovascular disease by more than 80%

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961699-7

7 January 2021

Two decades of progress in preventing vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961699-7

7 January 2021

The preventive polypill--much promise, insufficient evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961699-7

7 January 2021

Estimated global resources needed to attain universal coverage of maternal and newborn health services

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961699-7

7 January 2021

A financial road map to scaling up essential child health interventions in 75 countries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961699-7

7 January 2021

Evolution of hypertensive disease: a revolution in guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961699-7

7 January 2021

Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961699-7

7 January 2021

The effects of diabetes on the risks of major cardiovascular diseases and death in the Asia-Pacific region.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961699-7

7 January 2021

Survival and cause of death after myocardial infarction: the Danish MONICA study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961699-7

7 January 2021

Long-term survival and causes of death after stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961699-7

7 January 2021

Cardiovascular disease risk profiles.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961699-7

7 January 2021

beta Blockade after myocardial infarction: systematic review and meta regression analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961699-7

7 January 2021

Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961699-7

7 January 2021

Methods to assess the costs and health effects of interventions for improving health in developing countries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961699-7

7 January 2021

Adherence with statin therapy in elderly patients with and without acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961699-7

7 January 2021

Suboptimal statin adherence and discontinuation in primary and secondary prevention populations.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961699-7

7 January 2021

Adherence with statin therapy in secondary prevention of coronary heart disease in veterans administration male population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961699-7

7 January 2021

Long-term persistence in use of statin therapy in elderly patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961699-7

7 January 2021

Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961699-7

7 January 2021

Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961699-7

7 January 2021

Long term persistence with statin treatment in daily medical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961699-7

7 January 2021

Achieving the WHO/UNAIDS antiretroviral treatment 3 by 5 goal: what will it cost?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961699-7

7 January 2021

Can the world afford to save the lives of 6 million children each year?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961699-7

7 January 2021

Neonatal survival: a call for action

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961699-7

7 January 2021

The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961699-7

7 January 2021

Can non-physician health-care workers assess and manage cardiovascular risk in primary care?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961699-7

7 January 2021

Interventions to improve adherence to lipid lowering medication

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961699-7

7 January 2021

Interventions for improving adherence to treatment in patients with high blood pressure in ambulatory settings

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961699-7

7 January 2021

Achieving universal coverage with health interventions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961699-7

7 January 2021

Antiretroviral therapy in resource-poor settings: scaling up inequalities?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961699-7

7 January 2021

10.1016/S0140-6736(07)61699-7

Identifiers

DOI

1 reference

17 August 2017

1 reference

PubMed ID

18063025